Related Experiment Video
Updated: Jul 15, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
Published on: July 3, 2020
The bayesian bias correction method of the first-order approximation of nonlinear mixed-effects models for population
Takashi Funatogawa1, Ikuko Funatogawa
1Biometrics Department, Chugai Clinical Research Center Co., Ltd.. Tokyo. Japan. funatogawatks@chugai-pharm.co.jp
Abstract:
Population pharmacokinetic analysis usually employs nonlinear mixed-effects models. To estimate the parameters, Beal and Sheiner (1982) proposed the first-order method that employs a first-order Taylor series expansion around the means of random individual parameters. Because of the small computational burden and the high convergence proportion of maximization of the log likelihood function, this method is often used in practice. However, it is known that the estimates are biased. This paper proposes a simple procedure to reduce the bias. The proposed method maximizes the nonapproximated log likelihood functions of each individual given estimates of the population parameters derived from the first-order method, and the derived Bayes estimates of the random individual parameters are utilized to improve the estimates of the population mean parameters. We confirmed that the proposed method reduced the bias using simulated data and actual erythropoietin concentration data.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
